255 related articles for article (PubMed ID: 9264360)
1. The prognostic significance of p34cdc2 and cyclin D1 protein expression in prostate adenocarcinoma.
Kallakury BV; Sheehan CE; Ambros RA; Fisher HA; Kaufman RP; Ross JS
Cancer; 1997 Aug; 80(4):753-63. PubMed ID: 9264360
[TBL] [Abstract][Full Text] [Related]
2. The prognostic significance of proliferation-associated nucleolar protein p120 expression in prostate adenocarcinoma: a comparison with cyclins A and B1, Ki-67, proliferating cell nuclear antigen, and p34cdc2.
Kallakury BV; Sheehan CE; Rhee SJ; Fisher HA; Kaufman RP; Rifkin MD; Ross JS
Cancer; 1999 Apr; 85(7):1569-76. PubMed ID: 10193948
[TBL] [Abstract][Full Text] [Related]
3. Prediction of pathologic stage and postprostatectomy disease recurrence by DNA ploidy analysis of initial needle biopsy specimens of prostate cancer.
Ross JS; Figge H; Bui HX; del Rosario AD; Jennings TA; Rifkin MD; Fisher HA
Cancer; 1994 Nov; 74(10):2811-8. PubMed ID: 7954242
[TBL] [Abstract][Full Text] [Related]
4. Correlation of p34cdc2 cyclin-dependent kinase overexpression, CD44s downregulation, and HER-2/neu oncogene amplification with recurrence in prostatic adenocarcinomas.
Kallakury BV; Sheehan CE; Ambros RA; Fisher HA; Kaufman RP; Muraca PJ; Ross JS
J Clin Oncol; 1998 Apr; 16(4):1302-9. PubMed ID: 9552030
[TBL] [Abstract][Full Text] [Related]
5. Decreased levels of CD44 protein and mRNA in prostate carcinoma. Correlation with tumor grade and ploidy.
Kallakury BV; Yang F; Figge J; Smith KE; Kausik SJ; Tacy NJ; Fisher HA; Kaufman R; Figge H; Ross JS
Cancer; 1996 Oct; 78(7):1461-9. PubMed ID: 8839552
[TBL] [Abstract][Full Text] [Related]
6. Smad4 protein expression correlates with grade, stage, and DNA ploidy in prostatic adenocarcinomas.
Sheehan GM; Kallakury BV; Sheehan CE; Fisher HA; Kaufman RP; Ross JS
Hum Pathol; 2005 Nov; 36(11):1204-9. PubMed ID: 16260274
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of matrix metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 expression in prostate cancer.
Ross JS; Kaur P; Sheehan CE; Fisher HA; Kaufman RA; Kallakury BV
Mod Pathol; 2003 Mar; 16(3):198-205. PubMed ID: 12640098
[TBL] [Abstract][Full Text] [Related]
8. Expression of nuclear factor-kappa B and I kappa B alpha proteins in prostatic adenocarcinomas: correlation of nuclear factor-kappa B immunoreactivity with disease recurrence.
Ross JS; Kallakury BV; Sheehan CE; Fisher HA; Kaufman RP; Kaur P; Gray K; Stringer B
Clin Cancer Res; 2004 Apr; 10(7):2466-72. PubMed ID: 15073126
[TBL] [Abstract][Full Text] [Related]
9. Expression of the cell cycle regulatory proteins p34cdc2, p21waf1, and p53 in node negative invasive ductal breast carcinoma.
Kourea HP; Koutras AK; Scopa CD; Marangos MN; Tzoracoeleftherakis E; Koukouras D; Kalofonos HP
Mol Pathol; 2003 Dec; 56(6):328-35. PubMed ID: 14645695
[TBL] [Abstract][Full Text] [Related]
10. Survivin and Bcl-2 expression in prostatic adenocarcinomas.
Kaur P; Kallakury BS; Sheehan CE; Fisher HA; Kaufman RP; Ross JS
Arch Pathol Lab Med; 2004 Jan; 128(1):39-43. PubMed ID: 14692814
[TBL] [Abstract][Full Text] [Related]
11. Needle biopsy DNA ploidy status predicts grade shifting in prostate cancer.
Ross JS; Sheehan CE; Ambros RA; Nazeer T; Jennings TA; Kaufman RP; Fisher HA; Rifkin MD; Kallakury BV
Am J Surg Pathol; 1999 Mar; 23(3):296-301. PubMed ID: 10078920
[TBL] [Abstract][Full Text] [Related]
12. Assessment of biomarkers in paired primary and recurrent colorectal adenocarcinomas.
Seong J; Chung EJ; Kim H; Kim GE; Kim NK; Sohn SK; Min JS; Suh CO
Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1167-73. PubMed ID: 10613309
[TBL] [Abstract][Full Text] [Related]
13. Cell proliferation-associated proteins in endometrial carcinomas, including papillary serous and endometrioid subtypes.
Kallakury BV; Ambros RA; Hayner-Buchan AM; Sheehan CE; Malfetano JH; Ross JS
Int J Gynecol Pathol; 1998 Oct; 17(4):320-6. PubMed ID: 9785132
[TBL] [Abstract][Full Text] [Related]
14. CD10 expression pattern in prostatic adenocarcinoma: Elucidation of differences between Gleason's grades.
Kaur M; Verma S; Gupta R; Pant L; Singh S
Malays J Pathol; 2018 Apr; 40(1):57-60. PubMed ID: 29704385
[TBL] [Abstract][Full Text] [Related]
15. Quantitative immunohistochemical determination of cathepsin D levels in prostatic carcinoma biopsies. Correlation with tumor grade, stage, PSA level, and DNA ploidy status.
Ross JS; Nazeer T; Figge HL; Fisher HA; Rifkin MD
Am J Clin Pathol; 1995 Jul; 104(1):36-41. PubMed ID: 7541934
[TBL] [Abstract][Full Text] [Related]
16. Cyclin D1 overexpression in primary hypopharyngeal carcinomas.
Masuda M; Hirakawa N; Nakashima T; Kuratomi Y; Komiyama S
Cancer; 1996 Aug; 78(3):390-5. PubMed ID: 8697381
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of cyclin D1 expression in patients with node-positive breast carcinoma treated with adjuvant therapy.
Pelosio P; Barbareschi M; Bonoldi E; Marchetti A; Verderio P; Caffo O; Bevilacqua P; Boracchi P; Buttitta F; Barbazza R; Dalla Palma P; Gasparini G
Ann Oncol; 1996 Sep; 7(7):695-703. PubMed ID: 8905027
[TBL] [Abstract][Full Text] [Related]
18. [Pathologic characteristics of pseudohyperplastic prostatic adenocarcinoma].
Zhang HZ; Jiang ZM; Shi L
Zhonghua Bing Li Xue Za Zhi; 2007 Nov; 36(11):742-5. PubMed ID: 18307877
[TBL] [Abstract][Full Text] [Related]
19. Stage B prostate adenocarcinoma. Flow cytometric nuclear DNA ploidy analysis.
Montgomery BT; Nativ O; Blute ML; Farrow GM; Myers RP; Zincke H; Therneau TM; Lieber MM
Arch Surg; 1990 Mar; 125(3):327-31. PubMed ID: 2306181
[TBL] [Abstract][Full Text] [Related]
20. The significance of monoamine oxidase-A expression in high grade prostate cancer.
Peehl DM; Coram M; Khine H; Reese S; Nolley R; Zhao H
J Urol; 2008 Nov; 180(5):2206-11. PubMed ID: 18804811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]